Alva Review-Courier -

LINCOLN, Neb. (AP) — Most epilepsy patients taking cannabis-derived oil in a clinical trial at the University of Nebraska Medical Center continue to see improvement in their seizures.

The study, authorized by Nebraska lawmakers in 2015, showed that the majority of the 23 participating patients have experienced benefits from taking cannabidiol, commonly referred to as CBD oil. The Legislature approved the clinical trial the same year lawmakers rejected a bill to legalize medical cannabis for a variety of illnesses and conditions

Patients participating in the two-year trial have forms of epileps...